Tag Archives: AstraZeneca’s novel antibiotic candidate AZD0914

AstraZeneca’s novel antibiotic candidate AZD0914 designated as Qualified Infectious Disease Product and awarded Fast Track status by US FDA

Posted on 3, June 2014 by

London, UK, 03-6-2014 — /EuropaWire/ — AstraZeneca today announced that the US Food and Drug Administration (FDA) has designated its novel investigational drug AZD0914 as a Qualified Infectious Disease Product (QIDP) and awarded its development programme Fast Track status for the treatment … Read the full press release →

Posted in Healthcare, Pharma & Biotech, Technology, United Kingdom

Tagged , , , , ,